Table of Content

1 Study Coverage
1.1 Cancer Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Cancer Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cancer Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other Cancers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cancer Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Cancer Drugs Revenue by Region
2.2.1 Global Cancer Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Cancer Drugs Revenue by Region (2018-2024)
2.2.3 Global Cancer Drugs Revenue by Region (2024-2029)
2.2.4 Global Cancer Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Cancer Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Cancer Drugs Sales by Region
2.4.1 Global Cancer Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Cancer Drugs Sales by Region (2018-2024)
2.4.3 Global Cancer Drugs Sales by Region (2024-2029)
2.4.4 Global Cancer Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Cancer Drugs Sales by Manufacturers
3.1.1 Global Cancer Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Cancer Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cancer Drugs in 2022
3.2 Global Cancer Drugs Revenue by Manufacturers
3.2.1 Global Cancer Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Cancer Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Cancer Drugs Revenue in 2022
3.3 Global Key Players of Cancer Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Cancer Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cancer Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cancer Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Cancer Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cancer Drugs Sales by Type
4.1.1 Global Cancer Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Cancer Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Cancer Drugs Sales Market Share by Type (2018-2029)
4.2 Global Cancer Drugs Revenue by Type
4.2.1 Global Cancer Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Cancer Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Cancer Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Cancer Drugs Price by Type
4.3.1 Global Cancer Drugs Price by Type (2018-2024)
4.3.2 Global Cancer Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Cancer Drugs Sales by Application
5.1.1 Global Cancer Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Cancer Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Cancer Drugs Sales Market Share by Application (2018-2029)
5.2 Global Cancer Drugs Revenue by Application
5.2.1 Global Cancer Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Cancer Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Cancer Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Cancer Drugs Price by Application
5.3.1 Global Cancer Drugs Price by Application (2018-2024)
5.3.2 Global Cancer Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Cancer Drugs Market Size by Type
6.1.1 US & Canada Cancer Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Cancer Drugs Revenue by Type (2018-2029)
6.2 US & Canada Cancer Drugs Market Size by Application
6.2.1 US & Canada Cancer Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Cancer Drugs Revenue by Application (2018-2029)
6.3 US & Canada Cancer Drugs Market Size by Country
6.3.1 US & Canada Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Cancer Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Cancer Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Cancer Drugs Market Size by Type
7.1.1 Europe Cancer Drugs Sales by Type (2018-2029)
7.1.2 Europe Cancer Drugs Revenue by Type (2018-2029)
7.2 Europe Cancer Drugs Market Size by Application
7.2.1 Europe Cancer Drugs Sales by Application (2018-2029)
7.2.2 Europe Cancer Drugs Revenue by Application (2018-2029)
7.3 Europe Cancer Drugs Market Size by Country
7.3.1 Europe Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Cancer Drugs Sales by Country (2018-2029)
7.3.3 Europe Cancer Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Cancer Drugs Market Size
8.1.1 China Cancer Drugs Sales (2018-2029)
8.1.2 China Cancer Drugs Revenue (2018-2029)
8.2 China Cancer Drugs Market Size by Application
8.2.1 China Cancer Drugs Sales by Application (2018-2029)
8.2.2 China Cancer Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Cancer Drugs Market Size by Type
9.1.1 Asia Cancer Drugs Sales by Type (2018-2029)
9.1.2 Asia Cancer Drugs Revenue by Type (2018-2029)
9.2 Asia Cancer Drugs Market Size by Application
9.2.1 Asia Cancer Drugs Sales by Application (2018-2029)
9.2.2 Asia Cancer Drugs Revenue by Application (2018-2029)
9.3 Asia Cancer Drugs Sales by Region
9.3.1 Asia Cancer Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Cancer Drugs Revenue by Region (2018-2029)
9.3.3 Asia Cancer Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cancer Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Cancer Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Cancer Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Cancer Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Cancer Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Cancer Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Cancer Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Cancer Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Cancer Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Cancer Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Roche Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Overview
11.2.3 Novartis Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Novartis Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 Celgene
11.3.1 Celgene Company Information
11.3.2 Celgene Overview
11.3.3 Celgene Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Celgene Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celgene Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Overview
11.4.3 Bristol-Myers Squibb Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Bristol-Myers Squibb Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Amgen
11.5.1 Amgen Company Information
11.5.2 Amgen Overview
11.5.3 Amgen Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Amgen Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Amgen Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Johnson & Johnson Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Pfizer Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Overview
11.8.3 Takeda Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Takeda Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Takeda Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Eli Lilly Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Information
11.10.2 AstraZeneca Overview
11.10.3 AstraZeneca Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 AstraZeneca Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 AstraZeneca Recent Developments
11.11 Astellas
11.11.1 Astellas Company Information
11.11.2 Astellas Overview
11.11.3 Astellas Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Astellas Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Astellas Recent Developments
11.12 Merck & Co.
11.12.1 Merck & Co. Company Information
11.12.2 Merck & Co. Overview
11.12.3 Merck & Co. Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Merck & Co. Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck & Co. Recent Developments
11.13 Sanofi
11.13.1 Sanofi Company Information
11.13.2 Sanofi Overview
11.13.3 Sanofi Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Sanofi Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sanofi Recent Developments
11.14 Bayer
11.14.1 Bayer Company Information
11.14.2 Bayer Overview
11.14.3 Bayer Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Bayer Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bayer Recent Developments
11.15 Biogen Idec
11.15.1 Biogen Idec Company Information
11.15.2 Biogen Idec Overview
11.15.3 Biogen Idec Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Biogen Idec Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Biogen Idec Recent Developments
11.16 Eisai
11.16.1 Eisai Company Information
11.16.2 Eisai Overview
11.16.3 Eisai Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Eisai Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Eisai Recent Developments
11.17 Teva
11.17.1 Teva Company Information
11.17.2 Teva Overview
11.17.3 Teva Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Teva Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Teva Recent Developments
11.18 Otsuka
11.18.1 Otsuka Company Information
11.18.2 Otsuka Overview
11.18.3 Otsuka Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Otsuka Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Otsuka Recent Developments
11.19 Merck KGaA
11.19.1 Merck KGaA Company Information
11.19.2 Merck KGaA Overview
11.19.3 Merck KGaA Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Merck KGaA Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Merck KGaA Recent Developments
11.20 Ipsen
11.20.1 Ipsen Company Information
11.20.2 Ipsen Overview
11.20.3 Ipsen Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Ipsen Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Ipsen Recent Developments
11.21 AbbVie
11.21.1 AbbVie Company Information
11.21.2 AbbVie Overview
11.21.3 AbbVie Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.21.4 AbbVie Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 AbbVie Recent Developments
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Information
11.22.2 Gilead Sciences Overview
11.22.3 Gilead Sciences Cancer Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.22.4 Gilead Sciences Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Gilead Sciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cancer Drugs Industry Chain Analysis
12.2 Cancer Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cancer Drugs Production Mode & Process
12.4 Cancer Drugs Sales and Marketing
12.4.1 Cancer Drugs Sales Channels
12.4.2 Cancer Drugs Distributors
12.5 Cancer Drugs Customers
13 Market Dynamics
13.1 Cancer Drugs Industry Trends
13.2 Cancer Drugs Market Drivers
13.3 Cancer Drugs Market Challenges
13.4 Cancer Drugs Market Restraints
14 Key Findings in The Global Cancer Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Cancer Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Chemotherapy
Table 3. Major Manufacturers of Targeted Therapy
Table 4. Major Manufacturers of Immunotherapy
Table 5. Major Manufacturers of Hormonal Therapy (Biologic Therapy)
Table 6. Major Manufacturers of Others
Table 7. Global Cancer Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Cancer Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Cancer Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Cancer Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Cancer Drugs Revenue Market Share by Region (2018-2024)
Table 12. Global Cancer Drugs Revenue Market Share by Region (2024-2029)
Table 13. Global Cancer Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Cancer Drugs Sales by Region (2018-2024) & (K MT)
Table 15. Global Cancer Drugs Sales by Region (2024-2029) & (K MT)
Table 16. Global Cancer Drugs Sales Market Share by Region (2018-2024)
Table 17. Global Cancer Drugs Sales Market Share by Region (2024-2029)
Table 18. Global Cancer Drugs Sales by Manufacturers (2018-2024) & (K MT)
Table 19. Global Cancer Drugs Sales Share by Manufacturers (2018-2024)
Table 20. Global Cancer Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Cancer Drugs Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Cancer Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Cancer Drugs Price by Manufacturers 2018-2024 (USD/MT)
Table 24. Global Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Drugs as of 2022)
Table 26. Global Key Manufacturers of Cancer Drugs, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Cancer Drugs, Product Offered and Application
Table 28. Global Key Manufacturers of Cancer Drugs, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Cancer Drugs Sales by Type (2018-2024) & (K MT)
Table 31. Global Cancer Drugs Sales by Type (2024-2029) & (K MT)
Table 32. Global Cancer Drugs Sales Share by Type (2018-2024)
Table 33. Global Cancer Drugs Sales Share by Type (2024-2029)
Table 34. Global Cancer Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Cancer Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Cancer Drugs Revenue Share by Type (2018-2024)
Table 37. Global Cancer Drugs Revenue Share by Type (2024-2029)
Table 38. Cancer Drugs Price by Type (2018-2024) & (USD/MT)
Table 39. Global Cancer Drugs Price Forecast by Type (2024-2029) & (USD/MT)
Table 40. Global Cancer Drugs Sales by Application (2018-2024) & (K MT)
Table 41. Global Cancer Drugs Sales by Application (2024-2029) & (K MT)
Table 42. Global Cancer Drugs Sales Share by Application (2018-2024)
Table 43. Global Cancer Drugs Sales Share by Application (2024-2029)
Table 44. Global Cancer Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Cancer Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Cancer Drugs Revenue Share by Application (2018-2024)
Table 47. Global Cancer Drugs Revenue Share by Application (2024-2029)
Table 48. Cancer Drugs Price by Application (2018-2024) & (USD/MT)
Table 49. Global Cancer Drugs Price Forecast by Application (2024-2029) & (USD/MT)
Table 50. US & Canada Cancer Drugs Sales by Type (2018-2024) & (K MT)
Table 51. US & Canada Cancer Drugs Sales by Type (2024-2029) & (K MT)
Table 52. US & Canada Cancer Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Cancer Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Cancer Drugs Sales by Application (2018-2024) & (K MT)
Table 55. US & Canada Cancer Drugs Sales by Application (2024-2029) & (K MT)
Table 56. US & Canada Cancer Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Cancer Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Cancer Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Cancer Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 62. US & Canada Cancer Drugs Sales by Country (2024-2029) & (K MT)
Table 63. Europe Cancer Drugs Sales by Type (2018-2024) & (K MT)
Table 64. Europe Cancer Drugs Sales by Type (2024-2029) & (K MT)
Table 65. Europe Cancer Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Cancer Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Cancer Drugs Sales by Application (2018-2024) & (K MT)
Table 68. Europe Cancer Drugs Sales by Application (2024-2029) & (K MT)
Table 69. Europe Cancer Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Cancer Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Cancer Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Cancer Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 75. Europe Cancer Drugs Sales by Country (2024-2029) & (K MT)
Table 76. China Cancer Drugs Sales by Type (2018-2024) & (K MT)
Table 77. China Cancer Drugs Sales by Type (2024-2029) & (K MT)
Table 78. China Cancer Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Cancer Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Cancer Drugs Sales by Application (2018-2024) & (K MT)
Table 81. China Cancer Drugs Sales by Application (2024-2029) & (K MT)
Table 82. China Cancer Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Cancer Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Cancer Drugs Sales by Type (2018-2024) & (K MT)
Table 85. Asia Cancer Drugs Sales by Type (2024-2029) & (K MT)
Table 86. Asia Cancer Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Cancer Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Cancer Drugs Sales by Application (2018-2024) & (K MT)
Table 89. Asia Cancer Drugs Sales by Application (2024-2029) & (K MT)
Table 90. Asia Cancer Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Cancer Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Cancer Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Cancer Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Cancer Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Cancer Drugs Sales by Region (2018-2024) & (K MT)
Table 96. Asia Cancer Drugs Sales by Region (2024-2029) & (K MT)
Table 97. Middle East, Africa and Latin America Cancer Drugs Sales by Type (2018-2024) & (K MT)
Table 98. Middle East, Africa and Latin America Cancer Drugs Sales by Type (2024-2029) & (K MT)
Table 99. Middle East, Africa and Latin America Cancer Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Cancer Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Cancer Drugs Sales by Application (2018-2024) & (K MT)
Table 102. Middle East, Africa and Latin America Cancer Drugs Sales by Application (2024-2029) & (K MT)
Table 103. Middle East, Africa and Latin America Cancer Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Cancer Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Cancer Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Cancer Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Cancer Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Cancer Drugs Sales by Country (2018-2024) & (K MT)
Table 109. Middle East, Africa and Latin America Cancer Drugs Sales by Country (2024-2029) & (K MT)
Table 110. Roche Company Information
Table 111. Roche Description and Major Businesses
Table 112. Roche Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 113. Roche Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Roche Recent Developments
Table 115. Novartis Company Information
Table 116. Novartis Description and Major Businesses
Table 117. Novartis Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 118. Novartis Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Novartis Recent Developments
Table 120. Celgene Company Information
Table 121. Celgene Description and Major Businesses
Table 122. Celgene Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 123. Celgene Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Celgene Recent Developments
Table 125. Bristol-Myers Squibb Company Information
Table 126. Bristol-Myers Squibb Description and Major Businesses
Table 127. Bristol-Myers Squibb Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 128. Bristol-Myers Squibb Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Bristol-Myers Squibb Recent Developments
Table 130. Amgen Company Information
Table 131. Amgen Description and Major Businesses
Table 132. Amgen Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 133. Amgen Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Amgen Recent Developments
Table 135. Johnson & Johnson Company Information
Table 136. Johnson & Johnson Description and Major Businesses
Table 137. Johnson & Johnson Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 138. Johnson & Johnson Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Johnson & Johnson Recent Developments
Table 140. Pfizer Company Information
Table 141. Pfizer Description and Major Businesses
Table 142. Pfizer Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 143. Pfizer Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Pfizer Recent Developments
Table 145. Takeda Company Information
Table 146. Takeda Description and Major Businesses
Table 147. Takeda Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 148. Takeda Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Takeda Recent Developments
Table 150. Eli Lilly Company Information
Table 151. Eli Lilly Description and Major Businesses
Table 152. Eli Lilly Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 153. Eli Lilly Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Eli Lilly Recent Developments
Table 155. AstraZeneca Company Information
Table 156. AstraZeneca Description and Major Businesses
Table 157. AstraZeneca Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 158. AstraZeneca Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. AstraZeneca Recent Developments
Table 160. Astellas Company Information
Table 161. Astellas Description and Major Businesses
Table 162. Astellas Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 163. Astellas Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Astellas Recent Developments
Table 165. Merck & Co. Company Information
Table 166. Merck & Co. Description and Major Businesses
Table 167. Merck & Co. Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 168. Merck & Co. Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Merck & Co. Recent Developments
Table 170. Sanofi Company Information
Table 171. Sanofi Description and Major Businesses
Table 172. Sanofi Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 173. Sanofi Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Sanofi Recent Developments
Table 175. Bayer Company Information
Table 176. Bayer Description and Major Businesses
Table 177. Bayer Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 178. Bayer Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Bayer Recent Developments
Table 180. Biogen Idec Company Information
Table 181. Biogen Idec Description and Major Businesses
Table 182. Biogen Idec Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 183. Biogen Idec Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Biogen Idec Recent Developments
Table 185. Eisai Company Information
Table 186. Eisai Description and Major Businesses
Table 187. Eisai Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 188. Eisai Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Eisai Recent Developments
Table 190. Teva Company Information
Table 191. Teva Description and Major Businesses
Table 192. Teva Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 193. Teva Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Teva Recent Developments
Table 195. Otsuka Company Information
Table 196. Otsuka Description and Major Businesses
Table 197. Otsuka Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 198. Otsuka Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Otsuka Recent Developments
Table 200. Merck KGaA Company Information
Table 201. Merck KGaA Description and Major Businesses
Table 202. Merck KGaA Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 203. Merck KGaA Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 204. Merck KGaA Recent Developments
Table 205. Ipsen Company Information
Table 206. Ipsen Description and Major Businesses
Table 207. Ipsen Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 208. Ipsen Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 209. Ipsen Recent Developments
Table 210. AbbVie Company Information
Table 211. AbbVie Description and Major Businesses
Table 212. AbbVie Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 213. AbbVie Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 214. AbbVie Recent Developments
Table 215. Gilead Sciences Company Information
Table 216. Gilead Sciences Description and Major Businesses
Table 217. Gilead Sciences Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 218. Gilead Sciences Cancer Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 219. Gilead Sciences Recent Developments
Table 220. Key Raw Materials Lists
Table 221. Raw Materials Key Suppliers Lists
Table 222. Cancer Drugs Distributors List
Table 223. Cancer Drugs Customers List
Table 224. Cancer Drugs Market Trends
Table 225. Cancer Drugs Market Drivers
Table 226. Cancer Drugs Market Challenges
Table 227. Cancer Drugs Market Restraints
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Drugs Product Picture
Figure 2. Global Cancer Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Cancer Drugs Market Share by Type in 2022 & 2029
Figure 4. Chemotherapy Product Picture
Figure 5. Targeted Therapy Product Picture
Figure 6. Immunotherapy Product Picture
Figure 7. Hormonal Therapy (Biologic Therapy) Product Picture
Figure 8. Others Product Picture
Figure 9. Global Cancer Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Cancer Drugs Market Share by Application in 2022 & 2029
Figure 11. Blood Cancer
Figure 12. Breast Cancer
Figure 13. Gastrointestinal Cancer
Figure 14. Prostate Cancer
Figure 15. Respiratory/Lung Cancer
Figure 16. Other Cancers
Figure 17. Cancer Drugs Report Years Considered
Figure 18. Global Cancer Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Cancer Drugs Revenue 2018-2029 (US$ Million)
Figure 20. Global Cancer Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 21. Global Cancer Drugs Revenue Market Share by Region (2018-2029)
Figure 22. Global Cancer Drugs Sales 2018-2029 ((K MT)
Figure 23. Global Cancer Drugs Sales Market Share by Region (2018-2029)
Figure 24. US & Canada Cancer Drugs Sales YoY (2018-2029) & (K MT)
Figure 25. US & Canada Cancer Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Europe Cancer Drugs Sales YoY (2018-2029) & (K MT)
Figure 27. Europe Cancer Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. China Cancer Drugs Sales YoY (2018-2029) & (K MT)
Figure 29. China Cancer Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Asia (excluding China) Cancer Drugs Sales YoY (2018-2029) & (K MT)
Figure 31. Asia (excluding China) Cancer Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Cancer Drugs Sales YoY (2018-2029) & (K MT)
Figure 33. Middle East, Africa and Latin America Cancer Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 34. The Cancer Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 35. The Top 5 and 10 Largest Manufacturers of Cancer Drugs in the World: Market Share by Cancer Drugs Revenue in 2022
Figure 36. Global Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 37. Global Cancer Drugs Sales Market Share by Type (2018-2029)
Figure 38. Global Cancer Drugs Revenue Market Share by Type (2018-2029)
Figure 39. Global Cancer Drugs Sales Market Share by Application (2018-2029)
Figure 40. Global Cancer Drugs Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Cancer Drugs Sales Market Share by Type (2018-2029)
Figure 42. US & Canada Cancer Drugs Revenue Market Share by Type (2018-2029)
Figure 43. US & Canada Cancer Drugs Sales Market Share by Application (2018-2029)
Figure 44. US & Canada Cancer Drugs Revenue Market Share by Application (2018-2029)
Figure 45. US & Canada Cancer Drugs Revenue Share by Country (2018-2029)
Figure 46. US & Canada Cancer Drugs Sales Share by Country (2018-2029)
Figure 47. U.S. Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 48. Canada Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 49. Europe Cancer Drugs Sales Market Share by Type (2018-2029)
Figure 50. Europe Cancer Drugs Revenue Market Share by Type (2018-2029)
Figure 51. Europe Cancer Drugs Sales Market Share by Application (2018-2029)
Figure 52. Europe Cancer Drugs Revenue Market Share by Application (2018-2029)
Figure 53. Europe Cancer Drugs Revenue Share by Country (2018-2029)
Figure 54. Europe Cancer Drugs Sales Share by Country (2018-2029)
Figure 55. Germany Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. France Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. U.K. Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 58. Italy Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 59. Russia Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 60. China Cancer Drugs Sales Market Share by Type (2018-2029)
Figure 61. China Cancer Drugs Revenue Market Share by Type (2018-2029)
Figure 62. China Cancer Drugs Sales Market Share by Application (2018-2029)
Figure 63. China Cancer Drugs Revenue Market Share by Application (2018-2029)
Figure 64. Asia Cancer Drugs Sales Market Share by Type (2018-2029)
Figure 65. Asia Cancer Drugs Revenue Market Share by Type (2018-2029)
Figure 66. Asia Cancer Drugs Sales Market Share by Application (2018-2029)
Figure 67. Asia Cancer Drugs Revenue Market Share by Application (2018-2029)
Figure 68. Asia Cancer Drugs Revenue Share by Region (2018-2029)
Figure 69. Asia Cancer Drugs Sales Share by Region (2018-2029)
Figure 70. Japan Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. South Korea Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 72. China Taiwan Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 73. Southeast Asia Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 74. India Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 75. Middle East, Africa and Latin America Cancer Drugs Sales Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Cancer Drugs Revenue Market Share by Type (2018-2029)
Figure 77. Middle East, Africa and Latin America Cancer Drugs Sales Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Cancer Drugs Revenue Market Share by Application (2018-2029)
Figure 79. Middle East, Africa and Latin America Cancer Drugs Revenue Share by Country (2018-2029)
Figure 80. Middle East, Africa and Latin America Cancer Drugs Sales Share by Country (2018-2029)
Figure 81. Brazil Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. Mexico Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 83. Turkey Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 84. Israel Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 85. GCC Countries Cancer Drugs Revenue (2018-2029) & (US$ Million)
Figure 86. Cancer Drugs Value Chain
Figure 87. Cancer Drugs Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed